Jun 03, 2020
American Regent Introduces Estradiol Valerate Injection, USP­; AO Rated and Therapeutically Equivalent to Delestrogen®1, 2
Jan 17, 2020
Global Transdermal Patch Industry Outlook and Forecast 2020-2026: Dosage & Price Insights, Clinical Trials by Company, Drug Class, Indication & Patent Information
Aug 20, 2019
Forendo Pharma Commences Phase 1b Proof of Mechanism Study with its Lead Endometriosis Program, HSD17B1 Inhibitor FOR-6219
Jun 25, 2019
Hormone Replacement Therapy (HRT): Global Market Strategy Report 2016-2024 - Transdermal HRT Products Present Exciting Opportunities
May 28, 2019
Transdermal Drug Delivery Technologies, Markets and Competitive Landscape, 2018-2019 & Projections to 2028 Featuring 100 Companies and 105 Collaborations
Jan 02, 2019
Treating Low Hormone, High Oxidant Levels in Men Could Prevent Miscarriages
Jun 26, 2018
Enteris BioPharma Announces Positive Results from Expanded Phase 2a Clinical Trial of Ovarest® (oral leuprolide tablet) for Endometriosis
May 10, 2018
Transdermal Drug Delivery Markets, 2027 - Formulations, Carriers and Penetration Enhancers
Apr 25, 2018
Mylan Adds to Growing Women's Healthcare Portfolio with Launch of Generic for Oral Contraceptive Yaz®
Apr 10, 2018
Beckman Coulter Diagnostics Announces Worldwide Commercialization of the Access Sensitive Estradiol
Apr 06, 2018
Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)
Jan 17, 2018
Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
Dec 29, 2017
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace® Cream
Sep 14, 2017
Mylan Expands Women's Healthcare Portfolio with Launch of Generic Minastrin® 24 FE Tablets